Skin Disorders News

HOUSTON — Clinicians who treat patients with urticaria should be wary about the differences in clinical trajectories in patients when diagnosing and treating the disease, according to a presenter at the American Academy of Allergy, Asthma and Immunology Annual Meeting.

Topical pimecolimus treatment in children with atopic dermatitis appeared to have no association with increased risk of malignancy when compared with other data, according to recently published study results.

Healio.com will present live coverage of the American Academy of Allergy, Asthma and Immunology annual meeting today through Feb. 24 in Houston.

Newborn children lacking filaggrin and experiencing high transepidermal water loss at 2 days and 2 months are at an increased risk for atopic dermatitis, according to study results.

The absence of urticaria or angioedema in reactions to Hymenoptera stings with hypotension may represent the most relevant factor in identifying patients with mastocytosis, according to recent study results.

In vivo skin tests indicated sensitization to penicillin may develop within infectious mononucleosis, according to recent study results in Allergy, Asthma & Clinical Immunology.

Adults with eczema may be at a higher risk for developing cardiovascular diseases, according to recent study results in The Journal of Allergy and Clinical Immunology.

Two pharmaceutical companies have initiated prophylactic treatment of a patient with hereditary angioedema in a phase 2 clinical study, according to a press release.

Moderate-to-severe atopic dermatitis was found to have a potential association with central obesity and increased blood pressure in children and adolescents, according to recently published study results.

Data from a study published in the Journal of Allergy and Clinical Immunology demonstrate dupilumab was associated with a dose-dependent improvement in atopic dermatitis transcriptome compared with placebo.